What they do
KeepMED (initially called NINOX) is a start-up company dedicated to developing disruptive solutions for the treatment of Obstructive Sleep Apnea (OSA).
The company is developing a wearable device called the keePAP™, which is based on a novel, proprietary concept for the treatment of OSA. The keePAP™ device is comprised of a lightweight, unobtrusive nasal interface and a miniature battery-operated control unit that make it convenient for use both at home and while traveling.
The keePAP™ device will offer a new level of comfort and ease of use, resulting in a remarkable improvement in compliance and becoming the product of choice for the millions who suffer from OSA.
The OSA treatment market is an under-penetrated market valued at $4 billion globally, with anticipated substantial growth for the foreseeable future.

The founders
We feel very strong about Alex Rapoport, founder and CEO of KeepMED. A serial entrepreneur with 28 years of senior management and consulting experience in product development, business development, sales and marketing in the field of medical devices, Alex brings with him a wealth of knowledge, experience and skills.
We feel privileged to contribute to KeepMED’s global development.